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Acute lung injury (ALI) is a severe complication of orthotopic liver transplantation (OLT) with unclear underline mechanism.
Toll-like receptor 4 (TLR4) has been identified as a key receptor mediating inflammation. We hypothesized that TLR4-mediated
pulmonary inflammation may contribute to development of ALI during OLT. Patients with or without ALI were observed for
serum cytokines and expression of TLR4 on peripheral blood polymorphonuclear leukocytes (PMNs). Next, rats which underwent
orthotopic autologous liver transplantation (OALT) were divided into sham and model groups. Pulmonary function and the level
of TLR4 expression and cytokines were analyzed. Furthermore, the role of TLR4 inOALT-mediated ALI was assessed in rats treated
with TLR4-siRNA before OALT. The PMNs TLR4 expression and the serum TNF-𝛼 and IL-𝛽 level were higher in patients with
ALI than those with non-ALI. Interestingly, lung TLR4 expression was significantly increased after 8 hours of OALT with increased
levels of TNF-𝛼 and IL-𝛽, which lead to lung pathological damage and an increase of lung myeloperoxidase content. Moreover,
knockdown of TLR4 reduced lung cytokines release and reversed the above pathologic changes after OALT and finally improved
rats’ survival rate. In conclusion, TLR4 overexpression, potentially by stimulating proinflammatory cytokine overproduction,
contributes to the development of ALI after OLT.
1. Introduction
Liver transplantation is a major surgical procedure that is
associated with a high incidence of postoperative complica-
tions [1]. Acute lung injury (ALI) is a common complication
after orthotopic liver transplantation (OLT) that occurs in
34.2%–77.8% of patients receiving OLT and in 7.8%–23.6% of
patients with post-OLT ALI aggravated by acute respiratory
distress syndrome (ARDS), which itself carries a mortality
rate of 76.5% [2–4]. Overwhelming inflammation has been
shown to play an important role in the progress of ALI
induced by OLT [5], but the initiative mechanism of inflam-
mation remains unclear.
Toll-like receptor 4 (TLR4) is an importantmember of the
TLR family and can be activated by noxious stimuli to initiate
nuclear factor-𝜅B (NF-𝜅B) signaling and a downstream
inflammatory response [6, 7]. Overexpression of TLR4,
which is induced by different factors, including ischemia-
reperfusion, endotoxin, trauma, and mechanical ventilation,
has been shown to play a critical role in ALI [8–11]. TLR4
has also been shown to be involved in ischemia-reperfusion
injury pathophysiology in certain important organs such as
the liver and kidney as well as in the heart [12, 13]. At
present, there is no evidence to support the important role of
TLR4 in ALI after OLT. Therefore, a clarification of the role
played by TLR4 may help to explain the mechanism of ALI
induced by liver transplantation and may also contribute to
the development of effective intervention measures for ALI.
The purposes of the current study are (1) to observe
the neutrophil TLR4 expression in patients to provide clues
for TLR4 involved in ALI after OLT; (2) to dynamically
investigate the changes in lung pathology, TLR4 expression,
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and inflammatory mediators in lung tissue during orthotopic
autologous liver transplantation (OALT) in a rat model; (3) to
evaluate the relative importance of TLR4 in the development
of ALI during OLT using RNA interference (RNAi), which is
an established method for inhibiting target gene expression
in a rat model [14, 15].
2. Materials and Methods
2.1. Recruitment of Patients Undergoing OLT and Anesthesia
Procedure. This study was approved by the Research Ethics
Board of theThirdAffiliatedHospital, SunYat-senUniversity,
China (number ChiCTR-OCH-12002255). Informed consent
was obtained from every patient and their relatives. Twenty-
two ASA III or IV patients of both sexes (19males, 3 females),
33–59 years of age, weighing 49–74 kg, and undergoing OLT,
were studied. The anesthesia procedures and management
were performed by routine protocol at our hospital [4].
2.2. Diagnosis for Acute Lung Injury. All of the patients
received modified piggyback liver transplantation, a liver
transplantation technique of side-to-side caval anastomosis
during orthotopic hepatic transplantation without inferior
vena caval occlusion. Diagnosis of acute lung injury (ALI)
[16]was based on clinical findings, and diagnosis criteriawere
as follows: acute onset, PaO
2
/FiO
2
⩽ 300, bilateral pulmonary
infiltrates detected by X-ray, and pulmonary wedge pressure
(PCWP) ⩽ 18mmHg or no clinical evidence of congestive
heart failure.
2.3. Blood Sample Collected from Recipients. The peripheral
arterial blood samples (4mL) were collected for measure-
ment of TLR4 expression and concentration of TNF-𝛼 and
IL-1𝛽 at T
1
(after induction of anesthesia), T
2
(1 hr after
anhepatic phase), T
3
(4 hrs after graft reperfusion), and T
4
(24 hrs after graft reperfusion). 2mL of the blood sample was
stored in the EDTA anticoagulant tube for flow cytometry for
detection of TLR4 expression on the surface of PMNs cells
and the other 2mL was centrifuged at 3000 r/min for 10min
and then stored in −30∘C for assay of serum cytokines TNF-𝛼
and IL-1𝛽.
2.4. Animals. Male Sprague-Dawley (SD) rats, aged 8–10
weeks andweighing 220–250 g, were purchased fromMedical
Experimental Animal Center of Guangdong Province. All the
animal research protocols used in this study were approved
by the Institutional Animal Care and Use Committee of Sun
Yat-sen University in Guangzhou, China.
2.5. siRNA Preparation, Screening, and Delivering. Three 21-
nt siRNA duplexes targeting rat TLR4 gene (number NM
019178) were designed using the siRNA Target Finder and
Design Tool available at http://www.ambion.com and were
commercially obtained from Ribobio (Guangzhou, China).
Green fluorescent protein (GFP) siRNA, with no homology
to TLR4 gene, was taken as siRNA control. TLR4 siRNA was
found to have no toxic effect on hepatic stellate cells (HSC)
using CCK-8 assay (data not showed). After transfection
and incubation for 48 hrs, hepatic stellate cells (HSC) were
harvested and expression of TLR4 at bothmRNA and protein
levels was detected by real-time PCR (RT-PCR) andWestern
blot, respectively. TLR4 siRNAwithmaximum inhibition rate
was selected for in vivo experiments:
TLR4 siRNA1, target sequence 1: GCATAGAGG-
TACTTCCTAA.
5󸀠-GCAUAGAGGUACUUCCUAA dTdT-3󸀠 (sense).
3󸀠-dTdT CGUAUCUCCAUGAAGGAUU-5󸀠 (anti-
sense).
TLR4 siRNA2, target sequence 2: GCTTATATC-
CTTAAAGAAA.
5󸀠-GCUUAUAUCCUUAAAGAAAdTdT-3󸀠 (sense).
3󸀠-dTdT CGAAUAUAGGAAUUUCUUU-5󸀠 (anti-
sense).
TLR4 siRNA3, target sequence 3: CCTAGAACAT-
GTGGATCTT.
5󸀠-CCUAGAACAUGUGGAUCUU dTdT-3󸀠 (sense).
3󸀠-dTdT GGAUCUUGUACACCUAGAA-5󸀠 (anti-
sense).
After anesthesia with pentobarbital sodium (30mg/kg,
i.p.), rats received intratracheal injection of 500𝜇L of normal
saline (NS group), 500 𝜇L (50 nmol) of siRNA vector or TLR4
siRNA (NC and siRNA group). 48 hrs later, animals in the
NS, NC, and siRNA group received orthotopic autologous
liver transplantation (OALT) while rats in sham group only
received laparotomy and vessels separation without OALT.
2.6. Experiment Design. In first part of the experiment,
twenty-two patients were divided into ALI group and non-
ALI group according to their postoperative diagnosis after
OLT surgery. In second part of the experiment, the rat OALT
model was established according to our [17] and Jin et al.’s
[18] previous study. The entire anhepatic phase lasted for
20±1min. Rats were randomly divided into two groups. Rats
in Group S (sham operated, 𝑛 = 16) received abdominal
operation and liver dissection under anesthesia, without
cold perfusion and reperfusion. Rats in OALT model group
(Group M, 𝑛 = 16) all received OALT using the above-
described method [17, 18]. In Groups S and M, rats were
randomly killed at 4, 8, 16, and 24 hrs after liver reperfusion
(i.e., Groups M1, M2, M3, M4, resp.), and rats in Group
S were killed at corresponding times after liver liberation
(Groups S1, S2, S3, and S4, resp.; 𝑛 = 4 per subgroup). In
the third part of the experiment, eighty-eight animals were
randomly allocated to one of the four groups: the sham group
(Group S), the OALT group in which rats were administrated
saline as a control (Group NS), the OALT group in which
rats were administrated siRNA expression vector also as a
control (group NC), and the OALT group in which rats were
administrated TLR4 siRNA (group siRNA). The rats (𝑛 =
14 per group) were used to assess survival rates. Then the
remaining rats (𝑛 = 8 per group) were killed and samples
were collected at 8 hrs. All rats were anesthetized with pen-
tobarbital (30mg/kg body weight, i.p.). Tracheal intubation
Mediators of Inflammation 3
was performedwith inserting a 14-gauge intravenous catheter
which was then connected to small animal ventilators (ALC-
V9A; Shanghai Alcott Biotech Co., Ltd., Shanghai, China).
Rats were mechanically ventilated with a standard tidal vol-
ume (10mL/kg) ventilation protocol (inspiratory/expiratory
ratio of 1 : 1; respiratory rate 50 breaths/min; 100% oxygen).
All the animals were killed with deep anesthesia and lung
tissues and blood samples were collected for dynamic analysis
of pulmonary function, histopathology, TLR4 gene and
protein expression, and cytokines.
2.7. Arterial Blood Gas Analysis. The partial pressure of oxy-
gen (PaO
2
) was measured using an iSTAT portable blood gas
analyzer (G7+ chips, Abbott Laboratories, USA) according to
the provided manufacturer’s protocol.
2.8. Water Content of Lung in Rats. For assessing the severity
of alveolar edema, the wet weight of the superior lobe of the
right lung was accurately measured and baked to constant
weight (80∘C, 24 hrs) to calculate the water content of lung
as follows: water content = (lung wet weight − lung dry
weight)/lung wet weight × 100 [19].
2.9. Lung Histologic Evaluation in Rats. For histologic evalu-
ation, fresh lung sections were fixed in 10% buffered formalin
and embedded in paraffin; sections (4 𝜇m) were stained
with hematoxylin and eosin. A pathologist who was blinded
to research group assignment analyzed the samples and
determined the levels of lung injury according to a scoring
system as described by Derks and Jacobovitz Derks [20].
2.10. Reverse Transcription and Quantitative Real-Time PCR.
Total RNAwas extracted from lung samples by TRIzol (Invit-
rogen) according to the provided manufacturer’s protocol.
Reverse transcription (RT) of the lung samples was per-
formed according to the introduction of TaqManMicroRNA
Reverse Transcriptase Kit (Life Technologies, Gaithersburg,
MD, USA). Quantitative real-time PCR (qRT-PCR) was
performed using the TaqMan Universal PCR Master Mix,
NoAmpErase UNG (Life Technologies), and the Light Cycler
480 system (Roche, Switzerland). The relative expression of
the target genes (TLR4 and 𝛽-actin) was calculated by the
2
−ΔΔCt method. The qPCR primers were as follows:
TLR4 forward primer: 5󸀠-CCTAGGCACCAGGGT-
GTGAT-3󸀠.
TLR4 reverse primer: 5󸀠-TTGGTGACAATGCCG-
TGTTC-3󸀠.
𝛽-actin forward primer: 5󸀠-TGCTTGTGGTAGCCA-
CTGTA-3.󸀠
𝛽-actin reverse primer: 5󸀠-CCTCATTCTGGCTCG-
AGTAG-3󸀠.
2.11. Western Blot Analysis. Expression of TLR4 was assayed
using western blotting according to our previous study [17].
The primary antibodies used were monoclonal rabbit anti-
mouse TLR4 (1 : 500 dilution, Santa Cruz Biotechnology,
USA). The secondary antibody used was goat anti-rabbit
HRP-conjugated IgG (1 : 2000 dilution, Cell Signaling Tech-
nology, USA). Protein band density was measured using
UVP Labworks Imaging Analysis software (UVP Labworks,
Upland, CA, USA). The density measurement was correlated
to protein expression and normalized to 𝛽-actin.
2.12. Immunofluorescent Assay. Frozen sections of lung tissue
were immunofluorescent stained using polyclonal rabbit anti-
mouse NF-𝜅B P65 (1 : 1000 dilution, Cell Signaling Technol-
ogy, USA) according to our previous study [21].
2.13. Assay for Human Plasma TLR4 in Polymorphonuclear
Leukocytes by Flow Cytometry. Flow cytometry was per-
formed using phycoerythrin-Cy5-labelled monoclonal anti-
body for TLR4 (eBioscience, San Diego, USA) of human
according to the provided manufacturer’s protocol [22].
2.14. Assay for Human Serum TNF-𝛼, IL-1𝛽, and Rat Lung
Tissue and Serum TNF-𝛼 and IL-1𝛽 by Enzyme-Linked
Immunosorbent Assay (ELISA). The contents of TNF-𝛼 and
IL-1𝛽 in human serum were measured by ELISA kits (Rapid-
Bio Lab, California, USA) according to the provided manu-
facturer’s protocol of the kits. The levels of TNF-𝛼 and IL-
1𝛽 were expressed as pg/mL. Lung tissues harvested from
rats were homogenized with cold normal saline and then
centrifuged at 4000 r/min for 15 minutes. Supernatants were
transferred into fresh tubes for detection. The contents of
TNF-𝛼 and IL-1𝛽 in lung tissue and serum were measured
by respective ELISA kits (R&D Systems, Minneapolis, MN,
USA). The levels of TNF-𝛼 and IL-1𝛽 were expressed as pg/g
protein in lung tissue and pg/mL in serum sample.
2.15. Detection of Myeloperoxidase (MPO) Activity. MPO
activity in lungs was used as an indicator of peripheral blood
polymorphonuclear leukocytes (PMNs) infiltration. Using a
method previously described [23],MPOactivity was detected
and defined as the quantity of enzyme required degrading
1mmol of H
2
O
2
at 37∘C andwas expressed inmU/100mgwet
tissue.
2.16. Survival and Prognostic Analysis. To observe whether
or not TLR4 gene silencing improves the prognosis of liver
transplantation, we observed survival rates. The rats (𝑛 = 14
per group) receiving the same protocols were used to assess
survival rates. From the onset of reperfusion, animals were
monitored via video recording for 24 hrs. Two hours after
reperfusion, the survivors were transferred to their individual
cages and allowed free access to food and water.
2.17. Statistical Analysis. All data were analyzed using SPSS
12.0 software (SPSS, Chicago, Illinois). The normal distri-
bution data were expressed as mean ± standard deviation
or SEM. The differences among the groups were evaluated
by using one-way analysis of variance (ANOVA) followed
by the Tukey test. Correlation between different variables
was assessed by Spearman’s coefficient. Differences were
determined to be statistically significant at 𝑃 < 0.05.
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3. Result
3.1. The Levels of TLR4 on PMNs and Serum Inflammatory
Cytokines Were Elevated in Patients with ALI following OLT.
PMNs migration in circulation system has been shown to be
involved in lung inflammatory injury induced by LPS. TLR4
takes part in the initiation of inflammation. We observed
TLR4 expression on PMNs from peripheral blood of patients
received OLT in order to find out the relation between TLR4
and ALI induced by OLT. We first confirmed the different
levels of TLR4 on PMNs and the associated inflammatory
cytokines in patients (basic information in Table 1) who
received OLT surgery with or without ALI. As shown in
Table 1, patients with ALI exhibited more ascites (𝑃 = 0.01)
and longer anhepatic phase (𝑃 < 0.032). Moreover, severe
fluctuating of circulatory volume is assumed as more blood
loss volume (𝑃 = 0.034) and total output (𝑃 = 0.003) which
lead to more infusion of red blood cell (𝑃 = 0.021) existing in
patients with ALI compared to the non-ALI ones. Expression
of TLR4 on PMNs was increased gradually following OLT,
which was significantly higher in ALI group than that in
non-ALI group (𝑃 < 0.05) at 24 hrs after neohepatic
phase. Moreover, the TLR4 downstream cytokines TNF-𝛼
and IL-1𝛽 were synchronously increased after OLT, and ALI
group exhibited significantly increased TNF-𝛼 and IL-1𝛽
level (𝑃 < 0.05) at 24 hrs after neohepatic phase (Table 2).
These results indicated that inflammatory response especially
TLR4 associated pathway was activated in patients with ALI
following OLT.
3.2. ALI Induced by OALT in a Rat Model. In order to
investigate the underlying mechanism of ALI following OLT,
the OALT model was involved in our present study. The
model could well mimic the hemodynamic change during
liver transplantation (Table 3). Furthermore, we detected
pathological and functional change in the injured lung
at 4 hrs, 8 hrs, 16 hrs, and 24 hrs following OALT. Table 4
shows no statistical significance in body weight and anhep-
atic phase duration time of the animals. As a result, we
found collapse of pulmonary architecture; severe infiltration
of polymorphonuclear and mononuclear cells into intra-
alveolar, interstitial, and edematous interstitial space existed
(Figure 1(a)) in rats that received OALT, accompanied with
severe lung edema and dysfunctional pulmonary blood gas
barrier which reflected in higher water content of lung (𝑃 <
0.05, Figure 1(c)) and lower PaO
2
(𝑃 < 0.05, Figure 1(d)),
which were correlated with increased pathological injury
score (𝑃 < 0.05, Figure 1(b)). And these changes peaked at
8 hrs after reperfusion while they gradually recovered after
24 hrs. These above results showed that ALI occurred rapidly
afterOALT andmaximized at 8 hrs after liver transplantation.
3.3. Lung TLR4 Expression and Levels of TNF-𝛼 and IL-1𝛽
Were Increased following OALT. To investigate the underly-
ing mechanism that accounted for ALI induced by OALT,
we detected the TLR4 and its downstream cytokines which
play important roles in mediating inflammatory cascades.
As shown in Figures 2(a)–2(c), the mRNA and protein level
Table 1: Clinical characteristics of the ALI group and non-ALI
group during the peri-OLT period in patients.
Clinical characteristics ALI group Non-ALI group 𝑃 values
𝑁 8 14 —
Age 47 ± 8 45 ± 12 0.801
Weight 63 ± 9 62 ± 6 0.801
Sex (M : F) 7 : 1 12 : 2 0.999
CTP scores (A : B : C) 4 : 2 : 2 6 : 2 : 6 0.727
Concentrated red blood
cells (mL) 1313 ± 482 786 ± 467 0.021
∗
Fresh frozen plasma (mL) 2200 ± 307 2050 ± 620 0.532
Platelets (mL) 125 ± 71 114 ± 66 0.725
Cryoprecipitate (mL) 969 ± 281 855 ± 305 0.399
Albumin (mL) 303 ± 156 318 ± 101 0.781
Total input (mL) 7978 ± 999 7639 ± 1679 0.611
Blood loss volume (mL) 3925 ± 1136 2700 ± 1253 0.034∗
Urine output (mL) 1543 ± 580 1630 ± 809 0.793
Ascites (mL) 1150 ± 500 100 ± 50 0.01∗∗
Total output (mL) 7493 ± 2494 4537 ± 1571 0.003∗∗
Total operation time (min) 406 ± 61 390 ± 70 0.601
Preanhepatic phase (min) 91 ± 28 94 ± 27 0.809
Anhepatic phase (min) 59 ± 37 36 ± 5 0.032∗
Neohepatic phase (min) 259 ± 33 259 ± 57 0.978
Compared with the non-ALI group, ∗𝑃 < 0.05, ∗∗𝑃 < 0.01.
of TLR4 in lung tissue were simultaneously elevated from
4 hrs after reperfusion and peaked at the timepoint of 8 hrs
while they gradually decreased from 16 hrs after reperfusion.
Furthermore, OALT obviously increased the level of TNF-
𝛼 and IL-1𝛽 in lung tissue or serum from OALT groups, as
illustrated in Figures 2(d)–2(h). Interestingly, we also found
that the level of TNF-𝛼 and IL-1𝛽 in lung tissue reachedmax-
imum at 8 hrs. By contrast, the increase of serum cytokines
seemed to be earlier evident as TNF-𝛼 reached maximum
at 4 hrs while concentration of IL-1𝛽 peaked at 8 hrs. These
results indicated that TLR4 and its associated downstream
cytokines might act as the mediator of ALI progress which
was obviously injured at 8 hrs after reperfusion, and this
representative timepoint was chosen for further studies.
3.4. Knockdown of TLR4 Reduced NF-𝜅B p65 Nuclear Translo-
cation in Injured Lung following OALT. SiRNA adminis-
tration, as a gradually mature technology, was used in
our current study to knock down TLR4 induction. First,
in HSC cell line, we tested three TLR4 siRNA sequences
and determined that sequence 1 was the most effective in
inhibiting TLR4 protein and mRNA expression (Figures
3(a) and 3(c)). Then, we confirmed effective knockdown of
OALT-induced TLR4 protein expression in rat lung after
intranasal siRNA administration. TLR4 siRNA significantly
inhibited OALT-induced TLR4 protein (Figures 3(b) and
3(f)) and mRNA (Figure 3(e)) expression in rat lung lysates
whereas nonspecific siRNA administration had no effects
(Figure 3(b)) and intranasal siRNA administration had no
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Table 2: Perioperative differences in the expression of TLR4 on PMNs and the serum concentrations of TNF-𝛼 and IL-1𝛽 between patient
groups.
Groups T
1
T
2
T
3
T
4
ALI (𝑛 = 8)
TLR4 (MIF) 23.87 ± 13.33 36.59 ± 24.52 43.59 ± 31.05 75.54 ± 34.05bc
TNF-𝛼 (pg/mL) 73.53 ± 25.72 94.13 ± 40.97 94.80 ± 44.17a 289.43 ± 83.04ac
IL-1𝛽 (pg/mL) 57.52 ± 17.85 62.44 ± 24.09 96.58 ± 41.28 197.01 ± 58.85ac
Non-ALI (𝑛 = 14)
TLR4 (MIF) 27.25 ± 11.63 33.05 ± 13.96 38.08 ± 11.42 22.25 ± 7.97
TNF-𝛼 (pg/mL) 129.91 ± 80.55 139.67 ± 83.32 117.79 ± 49.52 163.67 ± 76.35
IL-1𝛽 (pg/mL) 51.94 ± 21.78 44.62 ± 23.40 29.97 ± 22.77 67.63 ± 26.15
MIF: mean fluorescence intensity; T1: after induction of anesthesia; T2: 1 hour after anhepatic phase; T3: 4 hours after neohepatic phase; and T4: 24 hours after
neohepatic phase. Data were expressed as the mean ± SD or median (interquartile range); a𝑃 < 0.05, b𝑃 < 0.01 versus T1; c𝑃 < 0.05 versus non-ALI.
Table 3: Hemodynamic changes during OALT in rats.
Baseline Vascular clamped Vascular unclamped 5min after vascular unclamped
Heart rate (BPM) Group sham 362 ± 7 — — —
Group model 361 ± 3 446 ± 9a 410 ± 11bd 225 ± 26ace
MAP (mmHg) Group sham 92 ± 3 — — —
Group model 93 ± 3 47 ± 5a 61 ± 5bc 42 ± 3af
BPM: beat per minute. Data are expressed as mean ± SD, 𝑛 = 3. a𝑃 < 0.01, b𝑃 < 0.05, versus baseline; c𝑃 < 0.01, d𝑃 < 0.05, versus vascular clamped; e𝑃 <
0.01, f𝑃 < 0.05, versus vascular unclamped.
Table 4: Rat body weight and anhepatic phase duration time in
studied groups.
Group Weight (g) Anhepatic phase (min)
S1 237.3 ± 21.0 —
S2 233.6 ± 15.6 —
S3 241.3 ± 14.1 —
S4 242.2 ± 15.2 —
IR4 h 240.6 ± 13.7 19.9 ± 0.6
IR8 h 229.1 ± 22.0 20.0 ± 0.5
IR16 h 243.1 ± 17.5 20.1 ± 0.6
IR24 h 243.1 ± 13.3 20.1 ± 0.6
Data are expressed as mean ± SD, 𝑛 = 8.
effects on liver TLR4 expression (Figures 3(b) and 3(d)).
Next, NF-𝜅B p65, as a downstream transcription factor of
TLR4 pathway, was involved in verifying the effects of TLR4
siRNA on signaling transduction. As shown in Figures 4(a)
and 4(b), NF-𝜅B p65 nuclear translocation was significantly
increased in NC group (𝑃 < 0.05 versus sham) while it
significantly decreasedwithTLR4 siRNA treatment (𝑃 < 0.05
versus group NC); by contrast, the expression of NF-𝜅B p65
in cytoplasm was opposite. Levels of lung and serum TNF-𝛼
and IL-1𝛽, important makers of inflammation during OALT
and OALT-induced ALI, were also decreased in rats admin-
istrated TLR4 siRNA compared with nonspecific siRNA
(Figures 4(d)-4(e)). Results demonstrated that TLR4/NF-𝜅B
pathway whichmediated lung inflammation was activated by
OALT.
3.5. Knockdown of TLR4 Attenuated MPO Activity. PMNs
migration plays an important role in the progress of ALI.
MPO is an indication of increased neutrophil infiltration.
Rats administrated TLR4 siRNA exhibited lower concen-
tration of myeloperoxidase in injured lung tissue than rats
administrated nonspecific siRNA after OALT (Figure 4(c)).
This result demonstrated that PMNsmigrated to injured lung
following OALT.
3.6. Knockdown of TLR4 Attenuated ALI Induced by OALT.
To determine the functional role of TLR4 expression on ALI
induced by OALT, we administrated TLR4 siRNA before rats
were subjected to OALT. As shown in Figure 5(b), we found
that knockdown of TLR4 significantly decreased mortality
compared with rats given nonspecific siRNA in the OALT
model (𝑃 < 0.05). These differences in mortality correlated
with decreased lung injury parameters afterOALT, evident by
significantly decreased pathological scores (Figures 5(a) and
5(c)) and water content of lung (Figure 5(d)) with increased
arterial PaO
2
(Figure 5(e)) compared with group NC (𝑃 <
0.01). Furthermore, TLR4 protein levels were positively
correlated with lung pathological scores (𝑟 = 0.8523; 𝑃 <
0.001), which indicated the important role of TLR4 activation
in the pathophysiologic process of ALI induced by OALT.
These results indicated that TLR4 induction served as an
important response to early stage of ALI induced by OALT
in vivo.
4. Discussion
Clinical outcome in the present study showed that high level
of TLR4 expression in circulating PMNs existed in patients
withALI afterOLT, accompaniedwith high level of cytokines,
providing clues of TLR4 overexpression involved in ALI
induced by OLT. Lung inflammatory injury was induced by
OALT in a rat model, evidenced by the increase of pathologi-
cal scores and the release of cytokines along with decreases
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Figure 1: ALI induced by OALT in rat model. (a) Lung histologymorphology. Lung sections were stained with hematoxylin and eosin (H&E)
and visualized at 200x magnification. (b) Evaluation scores for lung histopathology analysis. (c) Water content of lung. (d)The arterial blood
partial pressure of oxygen (PaO
2
). Groups M1, M2, M3, andM4 represented as collecting samples at liver reperfusion after 4 hrs, 8 hrs, 16 hrs,
and 24 hrs, respectively. Values were expressed as mean ± SEM. 𝑛 = 4 per group. NS: no statistical significance; ∗𝑃 < 0.05, ∗∗𝑃 < 0.01,
one-way ANOVA with Tukey test.
in PaO
2
and the high mRNA and protein expression of
lung tissue TLR4. These changes were more obvious at 8 hrs
after OALT. Silencing TLR4 expression reduced the nuclear
transfer of subunit P65 and attenuated ALI, after OALT.
These clinical and experiment results indicate that TLR4may
contribute to ALI induced by liver transplantation and that
TLR4 might be a potential intervention target.
Liver transplantation causes severe trauma and complex
pathophysiological alterations, such as hemodynamic insta-
bility, liver and intestinal ischemia-reperfusion (I/R) injury,
and the subsequent bacterial or endotoxin translocation and
neutrophil infiltration due to I/R injury, leading to large
amount of cytokines production and multiple inflammatory
pathway activation [24, 25]. Secondly, these mixed injury
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Figure 2: TLR4 gene and protein expression, concentration of TNF-𝛼 and IL-1𝛽, and MPO activity in lung tissue or serum during OALT in
a rat model. (a–c) TLR4 protein expression in lung tissue. (d) TLR4 mRNA expression in lung tissue. (e-f) TNF-𝛼, IL-1𝛽 concentrations in
lung tissue. (g-h) TNF-𝛼, IL-1𝛽 concentrations in serum. Groups M1, M2, M3, and M4 represented as collecting samples at liver reperfusion
after 4 hrs, 8 hrs, 16 hrs, and 24 hrs, respectively. Values are expressed as mean ± SEM. NS: no statistical significance; ∗𝑃 < 0.05, ∗∗𝑃 < 0.01,
one-way ANOVA with Tukey test.
factors result in the high incidence of postoperative compli-
cations. Lung is considered an early and vulnerable remote
organ affected by OLT, and ALI occurs after OLT in a
high incidence rate [3]. ALI has been characterized as an
acute inflammation with sequestration of neutrophils and
the subsequent enzymatic products in lung, resulting in
increased microvascular permeability and then interstitial
and pulmonary edema [26]. In our study, proinflammatory
cytokines TNF-𝛼 and IL-1𝛽 significantly increased in the cir-
culation and lungs in rats with ALI after liver transplantation.
The degree of lung injury was proportional to the TNF-𝛼
and IL-1𝛽 levels in rat lung tissue. These results suggested
that proinflammatory cytokines flooding, which may be
due to neutrophil infiltration and multiple inflammatory
pathway activation, played critical roles in amplifying lung
inflammation and injury.
As an important member of the TLR family, TLR4
is expressed on multiple cell types [27]. TLR4 is espe-
cially enriched in monocytes-macrophages, neutrophils, and
endothelial cells that are closely related to the inflammatory
response [28]. TLR4 overexpression has been shown in
injured lung induced by trauma or LPS [29–31]. In the current
study, we found higher expression of TLR4 on circulating
PMNs and higher levels of cytokines existed in patients
8 Mediators of Inflammation
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Figure 3: The effect of TLR4 siRNA on OALT-induced ALI in rats. (a) and (c) TLR4 gene and protein expression during screening for
siRNAs. Groups BC, NC, siRNA1, siRNA2, and siRNA3 in Awere treated with vehicle, negative control siRNA, siRNA1, siRNA2, and siRNA3,
respectively. (b) and (d) showed the effects of TLR4 siRNA on TLR4 protein expression in liver tissue. (b), (e), and (f) showed the effects of
TLR4 siRNA on TLR4 mRNA and protein expression in lung tissue. Groups S, NS, NC, and siRNA in (b) to (d) were treated with nothing,
saline, negative control siRNA, and targeting siRNA, respectively. Values were expressed as mean ± SEM. NS: no statistical significance;
∗
𝑃 < 0.05, ∗∗𝑃 < 0.01, one-way ANOVA with Tukey test.
with ALI than those in non-ALI patients. Interestingly, level
of TLR4 expression on circulating PMNs was increased
persistently even at 24 hours after neohepatic phase in ALI
patients, indicating that TLR4 expression on circulating
PMNs was closely related to prognosis of patients at the
early stage of reperfusion. Also, the TLR4 level was raised
transiently in non-ALI patients, which may be due to an
acute phase response. On the other hand, the migration and
activation of neutrophil have been demonstrated to initiate
and aggravate the lung inflammatory response induced by
traumatic factors or endotoxin [32, 33]. Neutrophils infiltra-
tion can be reflected by MPO activity which was released
by the intravascular degranulation of neutrophils [34]. We
also found high level of MPO activity in injured lung
tissue following OALT in the animal experiments, indicating
that neutrophils infiltration might play a critical role in
ALI induced by liver transplantation. Furthermore, TLR4
mRNA and protein expression were found to be dynamically
upregulated in lung tissues, which coincided with significant
increases in cytokines and enhanced MPO activity in rats.
All these data are consistent with the interpretation that
neutrophils infiltration and upregulation of TLR4 expression
participate in the development of ALI during OLT. Fur-
thermore, recently, TLR4 in endothelial cell was showed to
be a key determinant of LPS-induced PMNs infiltration in
lungs [35, 36]. TLR4 stimulation in endothelial cells induced
rapid expression of cell surface adhesion proteins, resulting
in increased neutrophils rolling and firm adhesion [36].
Massive numbers of PMNs accumulated in lungs in response
to activation of TLR4 [37]. However, study showed impaired
PMNs recruitment into the alveolar space in TLR4 null
mice [38]. Moreover, PMNs TLR4 has also been reported to
regulate interaction of PMNs with activation of endothelial
cells [39]. Another study using chimeric mice proved that
endothelial cell TLR4 rather than PMN TLR4 plays the
dominant role in LPS-induced PMNs infiltration in lungs
[36]. However, our study differs in that we examined the
role of TLR4 in a model of lung injury induced by multiple
factors from liver transplantationwhichwasmore in linewith
clinical practice and both endothelial cell TLR4 and PMN
TLR4 might be involved in the progress of ALI induced by
OALT.
Studies have confirmed that TLR4 could activate
transcription factors nuclear factor 𝜅B (NF-𝜅B), amplify
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difference versus Group NC, one-way ANOVA with Tukey test.
inflammatory responses, and lead to the injury (including
lung injury) of multiple tissues and end-organs induced
by endotoxin, massive transfusion, and trauma [40, 41].
The TLR4/NF-𝜅B pathway activation has an effect on the
production of inflammatory cytokines and chemokines,
resulting in PMNs infiltration and the subsequent
exaggerated inflammatory response [42]. Excess production
of proinflammatory cytokines such as TNF-𝛼 and IL-𝛽
can deteriorate the inflammatory process. In our current
study, TNF-𝛼 and IL-𝛽 acted as important response of
inflammation. Although there are various pathways involved
in cytokines synthesis, TLR4/NF-𝜅B pathway has been
proven to be playing an important role in cytokines
(TNF-𝛼 and IL-𝛽) productions; our current study also
demonstrated that the level of cytokines could reflect effects
on treatment of TLR4 siRNA, indicating the close relation
between TLR4/NF-𝜅B pathway activation and downstream
cytokines (TNF-𝛼 and IL-𝛽) production. Interestingly, a
recent study reported that TLR4 was a receptor for HMGB1-
mediated ALI after liver partial ischemia/reperfusion
injury [8]. This finding also supported our experimental
hypothesis.
Various studies have shown that the high expression
of TLR4 on separated lung cells plays a role in ALI [43–
46]. Although we found a high expression of TLR4 in ALI,
we did not investigate the cell type positioning of TLR4
siRNA, which will be involved in our study in the future.
In addition, study has shown that activation of TLR4 alone
or in conjunction with TLR2 could attenuate lung injury,
associated with promotion of prosurvival effects on alveolar
epithelium cell [47]. Similarly, TLR3-deficient mice were also
showed to be protected from lung damage after hyperoxic
exposure in vivo, accompanied with increased survival rate
[48]. Collectively, the above finding implies that the role of
TLRs in ALI is highly contextual. And, in the present study,
our data support the idea that TLR4 is themajor pathway that
mediates the OALT-induced ALI. However, the role of TLR2
and TLR3 in the OALT-induced ALI needs to be explored in
future studies to make the mechanism of TLRs acting on ALI
more clear.
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Figure 5: TLR4 siRNA reduced lung injury and resulted in an improvement of pulmonary function and rats survival. The effect of TLR4
siRNA on lung pathological change (a and c). Effect of TLR4 siRNA on survival (b). Survival time is calculated from the beginning of liver
reperfusion. Results were compared by Kaplan-Meier log rank test and Fisher exact test, 𝑛 = 14. (d) and (e) showed the effect of TLR4 siRNA
on pulmonary function evidenced by lung water content and PaO
2
. (f) showed correlations between TLR4 protein levels and pathological
scores. Groups S, NS, NC, and siRNA were treated with nothing, saline, negative control siRNA, and targeting siRNA, respectively. Values
were expressed as mean ± SEM. NS: no statistical significance; ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, one-way ANOVA with Tukey test.
In conclusion, our study provides compelling evidence
that the upregulation of TLR4 was involved in the ALI that
occurred in rats after liver transplantation and downregula-
tion of TLR4by siRNAwas proven to be an important therapy
for ALI induced by liver transplantation. Thus, the potential
manipulation of TLR4 activity to control lung injury may
permit advances in liver transplantation. Furthermore, vari-
ous TLR4 antagonists are under development for indications
like septic shock [49], suggesting that such strategies may
effectively reduce ALI early in the course of the disease and
Mediators of Inflammation 11
TLR4may also act as an important target in the development
of clinical drug for ALI treatment.
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